サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：生分解性ステントの世界市場：成長、将来展望、競合分析 (2022年～2030年)
市場調査レポート
商品コード
1166622

生分解性ステントの世界市場：成長、将来展望、競合分析 (2022年～2030年)

Biodegradable Stents Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
生分解性ステントの世界市場：成長、将来展望、競合分析 (2022年～2030年)
出版日: 2022年08月01日
発行: Acute Market Reports
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の生分解性ステント市場は2020年に、冠動脈ステント分野が最大のシェアを占めています。その要因として、世界各国で冠動脈疾患の有病率が上昇したことや、心臓専門医の間での経皮的冠動脈インターベンション処置の人気が高まったこと、心臓疾患の早期診断への関心増大、ステントの適用の拡大などが挙げられます。

地域別に見ると、2020年には欧州が最大のシェアを獲得しています。その背景には、早期診断に関連する国民の意識の高まり、老年人口における肥満の増加、近代的な医療施設へのアクセスのし易さといった要因があります。また、2022年から2030年にかけて、アジア太平洋は生分解性ステント市場の最速成長地域となる見通しです。その主な要因は、生命維持に不可欠なデバイスの高価格化、主要企業による市場参入の推進戦略、アジア太平洋地域で最大の市場として観測される巨大人口のインド、経済成長に伴う医療費増加などです。

材料別では、2020年には、ポリマーベースの生分解性ステントが最大のシェアを占めました。その主な要因として、金属ベースの生分解性ステントに伴うリスク、標的血管再血行再建術 (TVR) の低減、長期的な安全性、ステント血栓症や心筋梗塞のリスク低減などが挙げられます。

当レポートでは、世界の生分解性ステント市場について分析し、市場の基本構造やマクロ的・ミクロ的環境要因、全体的な市場規模の動向見通し (2020年～2030年)、製品別・材料別・地域別の詳細動向、主な市場促進・抑制要因、主要企業のプロファイルと成長戦略、といった情報を取りまとめてお届けいたします。

目次

第1章 序論

第2章 エグゼクティブサマリー

第3章 生分解性ステント市場：競合分析

  • 生分解性ステント市場：主要ベンダーの市場ポジショニング
  • 生分解性ステント市場のベンダーが採用した戦略
  • 主要な業界戦略
  • 階層分析 (2021年・2030年)

第4章 生分解性ステント市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の生分解性ステントの市場規模 (単位：100万米ドル、2020年～2030年)
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進・抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
  • PESTEL分析
  • ヘプタリシス分析
  • ビジネス上の重要な問題の分析：5つの根本原因の分析と関連ソリューション

第5章 生分解性ステント市場：製品別 (単位：100万米ドル、2020年～2030年)

  • 市場概要
  • 成長・収益分析 (2021年/2030年)
  • 市場区分
    • 冠動脈ステント
    • 末梢血管ステント

第6章 生分解性ステント市場：材料別 (単位：100万米ドル、2020年～2030年)

  • 市場概要
  • 成長・収益分析 (2021年/2030年)
  • 市場区分
    • ポリマー
    • 金属

第7章 地域分析

  • 市場概要
  • マクロ要因と市場への影響：ダッシュボード (2021年)
  • ポーターのファイブフォースモデル、地域別：ダッシュボード (2021年)
  • PESTEL要因の地域的影響：ダッシュボード (2021年)

第8章 北米の生分解性ステント市場 (単位：100万米ドル、2020年～2030年)

  • 市場概要
  • 生分解性ステント市場：製品別 (単位：100万米ドル、2020年～2030年)
  • 生分解性ステント市場：材料別 (単位：100万米ドル、2020年～2030年)
  • 生分解性ステント市場：地域別 (単位：100万米ドル、2020年～2030年)
    • 北米

第9章 英国・EU諸国の生分解性ステント市場 (単位：100万米ドル、2020年～2030年)

第10章 アジア太平洋の生分解性ステント市場 (単位：100万米ドル、2020年～2030年)

第11章 ラテンアメリカの生分解性ステント市場 (単位：100万米ドル、2020年～2030年)

第12章 中東・アフリカの生分解性ステント市場 (単位：100万米ドル、2020年～2030年)

第13章 企業プロファイル

  • Abbott Laboratories
  • Arterius Ltd.
  • Boston Scientific, Inc.
  • Biotronik
  • Kyoto Medical Corporation
  • Elixir Medical Corporation
  • Biosensors International
  • Terumo Europe NV
  • Ella CS
  • Arterial Remodeling Technologies SA
  • SMT (Sahajanand Group of Companiesの一部門)
図表

List of Tables

  • TABLE 1 Global Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 2 Global Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 3 North America Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 4 North America Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 5 U.S. Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 6 U.S. Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 7 Canada Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 8 Canada Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 9 Rest of North America Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 10 Rest of North America Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 11 UK and European Union Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 12 UK and European Union Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 13 UK Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 14 UK Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 15 Germany Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 16 Germany Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 17 Spain Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 18 Spain Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 19 Italy Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 20 Italy Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 21 France Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 22 France Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 23 Rest of Europe Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 24 Rest of Europe Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 25 Asia Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 26 Asia Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 27 China Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 28 China Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 29 Japan Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 30 Japan Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 31 India Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 32 India Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 33 Australia Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 34 Australia Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 35 South Korea Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 36 South Korea Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 37 Latin America Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 38 Latin America Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 39 Brazil Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 40 Brazil Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 41 Mexico Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 42 Mexico Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 43 Rest of Latin America Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 44 Rest of Latin America Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 45 Middle East and Africa Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 46 Middle East and Africa Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 47 GCC Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 48 GCC Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 49 Africa Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 50 Africa Biodegradable Stents Market By Material, 2020-2030, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Biodegradable Stents Market By Product, 2020-2030, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Biodegradable Stents Market By Material, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Biodegradable Stents Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Biodegradable Stents Market: Quality Assurance
  • FIG. 5 Global Biodegradable Stents Market, By Product, 2021
  • FIG. 6 Global Biodegradable Stents Market, By Material, 2021
  • FIG. 7 Global Biodegradable Stents Market, By Geography, 2021
  • FIG. 8 Market Geographical Opportunity Matrix - Global Biodegradable Stents Market, 2021
  • FIG. 9 Market Positioning of Key Biodegradable Stents Market Players, 2021
  • FIG. 10 Global Biodegradable Stents Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 11 Porters Five Force Model - Current, Midterm and Long Term Perspective
  • FIG. 12 See Saw Analysis
  • FIG. 13 PETEL Analysis
  • FIG. 14 Key Buying Criteria: Current and Long-Term Perspective
  • FIG. 15 Global Biodegradable Stents Market, Scenario Analysis, 2020 to 2030 (US$ Million)
  • FIG. 16 Heptalysis Analysis: Global Biodegradable Stents Market
  • FIG. 17 Five Whys Analysis
  • FIG. 18 Global Biodegradable Stents Market, By Product, 2021 Vs 2030, %
  • FIG. 19 Global Biodegradable Stents Market, By Material, 2021 Vs 2030, %
  • FIG. 20 U.S. Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 21 Canada Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 22 Rest of North America Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 23 UK Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 24 Germany Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 25 Spain Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 26 Italy Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 27 France Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Europe Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 29 China Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 30 Japan Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 31 India Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 32 Australia Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 33 South Korea Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 34 Rest of Asia Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 35 Brazil Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 36 Mexico Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 37 Rest of Latin America Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 38 GCC Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 39 Africa Biodegradable Stents Market (US$ Million), 2020 - 2030
  • FIG. 40 Rest of Middle East and Africa Biodegradable Stents Market (US$ Million), 2020 - 2030
目次
Product Code: 137530-08-22

The report titled "Biodegradable Stents Market- Growth, Future Prospects, and Competitive Analysis, 2022 - 2030" offers strategic insights into the overall biodegradable stents market along with the market size and estimates for the duration 2020 to 2030. The said research study covers in-depth analysis of multiple market segments based on type of products, materials, and different geographies. A key estimate for interventional cardiology discussed by Transcatheter Cardiovascular Therapeutics (TCT) and American College of Cardiology (ACC) in a meeting is that biodegradable stents will eventually replace conventional metallic stents in the near future. The key factors assisting the growth of biodegradable stents market are rising prevalence of coronary artery disease, increasing obesity due to sedentary lifestyle in young population, and increasing preference for biodegradable stents by cardiologists.

For the purpose of this study, the global biodegradable stents market is segmented on the basis of material type into polymer and metal. The product segment comprises market size of coronary and peripheral stents. Market size estimates and forecast for these segments for the period 2020 to 2030 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2022 to 2030, considering 2021 as the base year.

The geographical segmentation of biodegradable stents market comprised regions such as North America, Europe, Asia-Pacific, Latin America & Middle East and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2020 to 2030 and their CAGRs for the period 2022 to 2030 are provided in this report.

The biodegradable stents market is observed as the most diversified and competitive market comprising large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are Abbott Laboratories, Arterius Ltd., Boston Scientific, Inc., Biotronik, Kyoto Medical Corporation, Elixir Medical Corporation, Biosensors International, Terumo Europe NV, Ella CS, Arterial Remodeling Technologies SA, SMT (Part of Sahajanand Group of Companies), and Others.

In year 2020, coronary stents segment accounted for the largest share due to key driving factors rising prevalence of coronary artery diseases around the world, increasing preference of cardiologists for percutaneous coronary intervention procedures, increasing awareness associated with early diagnosis of cardiac diseases, and increasing application of stents. According to World Health Organization (WHO) estimates, around 17.3 million people died from cardiovascular diseases in 2008 and it is expected that each year more than 23.3 million people will die due to cardiovascular diseases; this trend is predicted to continue till 2030. However the Centers for Disease Control & Prevention (CDC) U.S. suggested that, the no. of deaths due to coronary artery diseases has started decreasing due to increase in the number of percutaneous coronary interventions being performed by using a range of coronary stents available in the global market.

In base year 2020, Europe accounted for the largest market share due to key drivers such as increasing public awareness related to early disease diagnosis, increasing obesity in geriatric population, and easy accessibility to modern medical facilities. According to Europe Heart Network, Each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). Hospital discharge rates for CVD as a whole have increased steadily in Europe over the past 25 years. During the forecast period 2022 - 2030, Asia-Pacific was observed as the fastest growing biodegradable stents market due to key drivers such as premium price life-essential device, push strategy approached by key players to penetrate market, India observed as the largest market in Asia-Pacific with huge population, and rising healthcare expenditure assisted by mounting economic growth.

In year 2020, polymer-based biodegradable stents accounted for the largest market share due to key driving factors such as risks associated with metal-based biodegradable stents, reduces target vessel revascularization (TVR), long term safety, and reduces risk of stent thrombosis and myocardial infarction. The most competent stents available in the market are zotarolimus-eluting stent (Resolute, Medtronic), cobalt-chromium everolimus-eluting stent (Xience, Abbott Vascular), and platinum-chromium everolimus-eluting stent (Promus, Boston Scientific). According to market experts, clinical research has shown that resorbable stents, offer comparable efficacy and safety profile to drug-eluting stents. Thus, high prevalence of coronary artery diseases across the globe around the world, rising preference of cardiologists towards percutaneous coronary intervention procedures, and increasing uptake of use of stents are expected to make a significant contribution to the soaring revenue of this segment in the forecast period.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Biodegradable Stents market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Biodegradable Stents market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Coronary Stents
  • Peripheral Stents

Material

  • Polymer
  • Metal

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Biodegradable Stents market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Biodegradable Stents market?
  • Which is the largest regional market for Biodegradable Stents market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Biodegradable Stents market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Biodegradable Stents market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Biodegradable Stents Market
  • 2.2. Global Biodegradable Stents Market, By Product, 2021 (US$ Million)
  • 2.3. Global Biodegradable Stents Market, By Material, 2021 (US$ Million)
  • 2.4. Global Biodegradable Stents Market, By Geography, 2021 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2021
  • 2.6. Key Buying Criteria
  • 2.7. Key Case Reports
  • 2.8. Scenario Analysis
    • 2.8.1. Optimistic estimates and analysis
    • 2.8.2. Realistic estimates and analysis
    • 2.8.3. Pessimistic estimates and analysis
  • 2.9. Market Profiling
  • 2.10. Sales and Marketing Plan
  • 2.11. Top Market Conclusions
  • 2.12. Strategic Recommendations

3. Biodegradable Stents Market: Competitive Analysis

  • 3.1. Market Positioning of Key Biodegradable Stents Market Vendors
  • 3.2. Strategies Adopted by Biodegradable Stents Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Biodegradable Stents Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Biodegradable Stents Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape
  • 4.8. Heptalysis Analysis
  • 4.9. Critical Investigation of Business Problems Through Five Whys Root Cause Analysis & Relevant Solutions

5. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Coronary Stents
    • 5.3.2. Peripheral Stents

6. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Polymer
    • 6.3.2. Metal

7. Geographic Analysis

  • 7.1. Market Overview
  • 7.2.Macro Factors versus Market Impact: Dashboard, 2021
  • 7.3. Porters Five Force Model Across Geography: Dashboard, 2021
  • 7.4. Impact of PESTEL factors Across Geography: Dashboard, 2021

8. North America Biodegradable Stents Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
  • 8.3. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
  • 8.4.Biodegradable Stents Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.North America
      • 8.4.1.1. U.S.
        • 8.4.1.1.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.1.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 8.4.1.2. Canada
        • 8.4.1.2.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.2.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 8.4.1.3. Rest of North America
        • 8.4.1.3.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.3.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)

9. UK and European Union Biodegradable Stents Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
  • 9.3. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
  • 9.4.Biodegradable Stents Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.UK and European Union
      • 9.4.1.1. UK
        • 9.4.1.1.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.1.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 9.4.1.2. Germany
        • 9.4.1.2.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.2.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 9.4.1.3. Spain
        • 9.4.1.3.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.3.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 9.4.1.4. Italy
        • 9.4.1.4.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.4.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 9.4.1.5. France
        • 9.4.1.5.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.5.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 9.4.1.6. Rest of Europe
        • 9.4.1.6.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.6.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)

10. Asia Pacific Biodegradable Stents Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
  • 10.3. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
  • 10.4.Biodegradable Stents Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Asia Pacific
      • 10.4.1.1. China
        • 10.4.1.1.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 10.4.1.1.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 10.4.1.2. Japan
        • 10.4.1.2.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 10.4.1.2.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 10.4.1.3. India
        • 10.4.1.3.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 10.4.1.3.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 10.4.1.4. Australia
        • 10.4.1.4.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 10.4.1.4.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 10.4.1.5. South Korea
        • 10.4.1.5.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 10.4.1.5.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 10.4.1.6. Rest of Asia Pacific
        • 10.4.1.6.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 10.4.1.6.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)

11. Latin America Biodegradable Stents Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
  • 11.3. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
  • 11.4.Biodegradable Stents Market: By Region, 2020-2030, USD (Million)
    • 11.4.1.Latin America
      • 11.4.1.1. Brazil
        • 11.4.1.1.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 11.4.1.1.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 11.4.1.2. Mexico
        • 11.4.1.2.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 11.4.1.2.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 11.4.1.3. Rest of Latin America
        • 11.4.1.3.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 11.4.1.3.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)

12. Middle East and Africa Biodegradable Stents Market, 2020-2030, USD (Million)

  • 12.1. Market Overview
  • 12.2. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
  • 12.3. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
  • 12.4.Biodegradable Stents Market: By Region, 2020-2030, USD (Million)
    • 12.4.1.Middle East and Africa
      • 12.4.1.1. GCC
        • 12.4.1.1.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 12.4.1.1.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 12.4.1.2. Africa
        • 12.4.1.2.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 12.4.1.2.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)
      • 12.4.1.3. Rest of Middle East and Africa
        • 12.4.1.3.1. Biodegradable Stents Market: By Product, 2020-2030, USD (Million)
        • 12.4.1.3.2. Biodegradable Stents Market: By Material, 2020-2030, USD (Million)

13. Company Profile

  • 13.1. Abbott Laboratories
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Arterius Ltd.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Boston Scientific, Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Biotronik
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Kyoto Medical Corporation
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Elixir Medical Corporation
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Biosensors International
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Terumo Europe NV
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Ella CS
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Arterial Remodeling Technologies SA
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. SMT (Part of Sahajanand Group of Companies)
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives